Overview

Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive Disorder

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose is to evaluate the safety and usefulness of the investigational drug, vilazodone in depression.
Phase:
Phase 2
Details
Lead Sponsor:
Pharmacology Research Institute
Treatments:
Vilazodone Hydrochloride